Skip to main content

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Projects

RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2

IP: Pere Soler Palacín
Collaborators: Miriam Gonzalez Amores, Berta Sofia Fernandez Ledesma, Tamara Del Rio Higueras, Ariadna Martín Balcells, Amaia Latasa Arrazubi, Laura Roig Soria, Noemí Giménez Sanz, Olga Sánchez- Maroto Carrizo, Maria Soraya Badia Ventura
Funding agency: EUROPEAN COMMISSION
Funding: 475000
Reference: RBDCOV_HE-HLTH-CORONA2021
Duration: 01/12/2021 - 31/05/2024

Related news

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

The study, which is part of the European RECOMB project, is currently recruiting volunteers.

This clinical trial is part of the European project RBDCOV, led by HIPRA in which Vall d'Hebron participates, whose recruitment is still open.

Related professionals

Silvia Muñoz Caller

Silvia Muñoz Caller

Research technician
Psychiatry, Mental Health and Addictions
Read more
Josep Paunellas Albert

Josep Paunellas Albert

Shock, Organ Dysfunction and Resuscitation
Read more
Alejandro Balleste Nadal

Alejandro Balleste Nadal

Research assistant
Cardiovascular Diseases
Read more
Antonio Alvarez Gonzalez

Antonio Alvarez Gonzalez

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.